Trials / Sponsors / Thomas Lund
Thomas Lund
Academic / Other · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Self-administration of Subcutaneous Elranatamab in the Patients' Homes. Multiple Myeloma | Phase 2 | 2025-01-29 |
| Recruiting | Home Treatment With Carfilzomib in Patients With Multiple Myeloma Multiple Myeloma | — | 2022-12-15 |
| Completed | Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project. Multiple Myeloma | — | 2022-04-01 |
| Completed | Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma Multiple Myeloma | — | 2021-05-01 |
| Completed | Bone Healing During Ninlaro Exposure Multiple Myeloma | Phase 2 | 2019-10-24 |
| Completed | Prolonged Protection From Bone Disease in Multiple Myeloma Multiple Myeloma | Phase 4 | 2015-01-01 |